ClinicalTrials.Veeva

Menu

Food Matrix and Genetic Variability as Determinants of Bioavailability and Biological Effects of Beta-cryptoxanthin and Phytosterols (foodmagenpol)

M

Majadahonda Iron Gate University

Status and phase

Completed
Phase 1

Conditions

Osteoporosis
Hypercholesterolemia

Treatments

Dietary Supplement: b-cryptoxanthin plus phytosterols

Study type

Interventional

Funder types

Other

Identifiers

NCT02065024
AGL2012-39503-C02-02

Details and patient eligibility

About

Regular consumption of a beverage containing β-cryptoxanthin (b-Cx) and plant sterols (Ps) has been shown to exert a synergic effect in reducing cardiovascular risk and bone remodeling markers (formation and resorption). The present project aims to assess the influence of technological treatment and genetic variability on the bioavailability and the health effects of the added components (Ps, b-Cx), in particular to their potential role in prevalent disorders.In vitro and in vivo studies will be carried out to this effect. In vitro and in vivo studies (human intervention study) will be performed and cardiovascular, bone turnover and inflammation markers will be evaluated. Additionally, an in vitro colonic fermentation model and cell cultures will be used to explore anticarcinogenic effects and potential cytotoxicity.

Enrollment

40 patients

Sex

Female

Ages

45 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Post-menopausal women; mild hypercholesterolemia

Exclusion criteria

  • Use of cholesterol lowering drugs, hormonal therapy, vitamin and herbs supplements use

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

40 participants in 2 patient groups, including a placebo group

b-cryptoxanthin plus phytosterols
Active Comparator group
Description:
Fruit and milk based beverage enriched with b-cryptoxanthin and phytosterols
Treatment:
Dietary Supplement: b-cryptoxanthin plus phytosterols
control
Placebo Comparator group
Description:
Fruit and milk based beverage not enriched
Treatment:
Dietary Supplement: b-cryptoxanthin plus phytosterols

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems